Justin Moed
- Democratic
- Representative
- District 97
Provides that a drug, biological product, or medical device that has been designated as a breakthrough therapy under federal law may be made available to a qualified patient and offered by a physician as a part of the patient's medical treatment. Specifies that a civil or criminal cause of action is not created against a manufacturer or health care provider for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device.
No votes to display
Representatives Lucas and Miller K added as coauthors
Authored by Representative Moed
First reading: referred to Committee on Public Health
Bill Text Versions | Format |
---|---|
Introduced House Bill (H) |
Document | Format |
---|---|
Fiscal Note: HB1158.01.INTR.FN001 |
Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.